Mulberry and cherry anthocyanin consumption prevents oxidative stress and inflammation in diet‐induced obese mice

Molecular Nutrition and Food Research - Tập 60 Số 3 - Trang 687-694 - 2016
Tao Wu1,2, Jinjin Yin2, Guohua Zhang3, Hairong Long4, Xiaodong Zheng1
1Department of Food Science and Nutrition, Zhejiang University, Hangzhou, China
2Key Laboratory of Food Nutrition and Safety (Tianjin University of Science and Technology), Ministry of Education, Tianjin, PR China
3College of Life Science, Shanxi University, Taiyuan, China
4National Engineering Laboratory of Southwest Endangered Medicinal Resources Development, Guangxi Botanical Garden of Medicinal Plants,, Nanning, China

Tóm tắt

ScopeThis study aimed to determine whether cherry anthocyanin (CA) and mulberry anthocyanin (MA) can alleviate oxidative stress and inflammation associated with developing obesity in mice fed with high‐fat diet (HFD).Methods and resultsCA and MA were added in the daily food of mice throughout the experiment. Sixty mice were randomly divided into two groups: a low‐fat diet (LFD, n = 12) group and HFD (n = 48) group. Mice in the HFD group were supplied with a HFD for 8 wks to induce obesity. The HFD‐fed mice were then divided into four subgroups for another 8‐wk experiment. The subgroups included the control group, HFD plus Orlistat group, and HFD plus CA or MA group, with each group consisting of 12 mice. Consumption of CA and MA at 200 mg/kg food reduced bodyweight gain by 29.6 and 32.7%, respectively, in HFD‐fed C57BL/6 mice. CA and MA supplementation could effectively improve the lipid profiles, decrease serum glucose and leptin levels, reduce MDA production, increase SOD and GPX activities, and down‐regulate the expression of the TNFα, IL‐6, iNOS, and NF‐кB genes.ConclusionTherefore, MA and CA can potentially alter bodyweight by alleviating oxidative stress and inflammation in diet‐induced obesity.

Từ khóa


Tài liệu tham khảo

10.1146/annurev-publhealth-031914-122415

10.1111/obr.12121

10.1210/en.2013-1159

10.1016/j.healun.2013.01.531

10.1016/j.tem.2014.03.009

10.2147/DDDT.S58459

10.1080/14786419.2012.706299

Seifu D., 2012, Medicinal Plants as Antioxidant Agents: Understanding Their Mechanism of Action and Therapeutic Efficacy, 97

10.1080/10408398.2015.1030064

10.1093/jn/133.7.2125

10.1002/mnfr.200900026

10.1021/jf902852d

10.3945/jn.111.143677

10.1038/ijo.2009.266

10.1016/j.foodchem.2013.03.046

10.1021/jf401171k

10.1039/c3fo60251f

10.1146/annurev-arplant-050312-120142

Reagan‐Shaw S., Dose translation from animal to human studies revisited, FASEB J., 22, 659, 10.1096/fj.07-9574LSF

CDER U. Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research 2005.

10.1016/S0021-9258(18)64849-5

10.1016/j.jim.2004.01.003

10.1271/bbb.130253

10.1021/jf9030772

10.1016/j.foodres.2011.11.021

10.1016/j.foodres.2015.01.033

10.1080/10408398.2013.805316,0

10.1016/j.nut.2015.04.015

10.1016/j.jnutbio.2013.11.002

10.1021/jf071993o

10.1079/PAVSNNR20105029

10.1016/j.fsi.2013.04.020

10.1080/10715760600758522

10.3390/molecules17021483

10.1021/jf4051599

10.1021/acs.jafc.5b00963

10.3136/fstr.18.315

10.1016/j.bbagen.2011.09.004

Jin X., 2013, Delphinidin‐3‐glucoside protects against oxidized low‐density lipoprotein‐induced mitochondrial dysfunction in vascular endothelial cells via the sodium‐dependent glucose transporter SGLT1, PLoS One, 8, 1

10.1016/j.foodchem.2011.11.070

10.1007/s11130-009-0135-y

10.1007/s11154-014-9302-z

10.1093/ajcn/83.2.461S

10.1146/annurev-immunol-031210-101322

10.1016/j.jff.2015.02.030